Duarte, CA Clinical Trials Report — April 2026

For individuals in Duarte, CA, considering participation in clinical trials, April 2026 presents a mix of urgent opportunities and new research avenues. Currently, 537 clinical trials are actively recruiting across 73 research facilities in the city. A significant number of these, 47 trials, are slated to close enrollment within the next 90 days, meaning interested participants should act quickly. Notably, 6 of these rapidly closing trials are still seeking healthy volunteers, offering a chance to contribute to medical science without a specific health condition.

Act Now: Trials Closing Soon

Patients with certain health conditions have a limited window to join studies before enrollment concludes. Trials focused on various cancers and blood disorders are among those with impending deadlines for participation. Conditions with trials closing soon include:

• Myelodysplastic syndromes (4 trials)
• Colorectal cancer (3 trials)
• Acute myeloid leukemia (3 trials)
• Gastric cancer (3 trials)
• Malignant solid neoplasm (3 trials)
• Lung non-small cell carcinoma (2 trials)
• Anatomic stage iii breast cancer ajcc v8 (2 trials)
• Anatomic stage ii breast cancer ajcc v8 (2 trials)
• Colorectal cancer stage ii (2 trials)
• Acute leukemia (2 trials)

If you or a loved one are managing one of these conditions, exploring these trials promptly could be beneficial.

New Opportunities in Duarte Research

This month, Duarte saw the opening of 5 new clinical trials, an increase from the 2 trials that launched in March 2026, indicating a growing research landscape. While none of these 5 new trials are accepting healthy volunteers, there are still 31 total trials recruiting healthy participants in Duarte. Among the new studies, there are 3 drug trials, 2 biological trials, 1 device trial, and 1 procedure trial.

Several notable Phase 3 drug trials have opened, sponsored by major pharmaceutical companies, offering advanced treatment options for serious conditions:

• Incyte Corporation is sponsoring NCT07522073, "A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma." This Phase 3 study aims to enroll 588 participants to evaluate the effectiveness and safety of a new combination therapy for metastatic pancreatic cancer.
• Boehringer Ingelheim has launched NCT07544654, "A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy." This Phase 3 trial, open to adults with advanced extrapulmonary neuroendocrine cancer, seeks 390 participants to determine if a study medicine called obrixtamig, combined with standard chemotherapy, improves survival.

Other new trials this month are exploring treatments for a range of conditions, including:

• Advanced/metastatic colorectal adenocarcinoma
• Colorectal cancer
• Esophageal adenocarcinoma
• Gastric adenocarcinoma
• Gastroesophageal adenocarcinoma
• Recurrent astrocytoma, idh-mutant, grade 4
• Recurrent glioblastoma, idh-wildtype
• Solid tumors
• Unresectable locally advanced or metastatic extrapulmonary neuroendocrine carcinomas

These new studies are primarily sponsored by industry leaders like Bayer, Boehringer Ingelheim, Dispatch Biotherapeutics, and Incyte Corporation, alongside academic contributions from City of Hope Medical Center.

Duarte's Leading Research Facilities

Duarte is a prominent hub for clinical research, largely due to the extensive work conducted by the City of Hope system. These facilities consistently run a high volume of clinical trials, making them key destinations for individuals seeking to participate in medical research:

• City of Hope Medical Center (152 trials)
• City of Hope (129 trials)
• City of Hope Comprehensive Cancer Center (95 trials)
• City of Hope National Medical Center (45 trials)
• Research Site (24 trials)
• City of Hope (City of Hope National Medical Center, City of Hope Medical Center) (11 trials)
• City of Hope Cancer Center (7 trials)
• City of Hope - Duarte Cancer Center (4 trials)
• City of Hope - Duarte (4 trials)
• City of Hope Orange County Lennar Foundation Cancer Center (4 trials)
• City Of Hope (4 trials)
• City Of Hope National Medical Center (3 trials)

The various City of Hope campuses and centers collectively represent the vast majority of research opportunities in Duarte, specializing in a broad spectrum of medical fields, particularly oncology.

Expanding Your Search: Nearby California Cities

While Duarte offers a significant number of clinical trial opportunities, individuals may also find options in other communities across California. Nearby cities with active trials include:

• San Francisco (21 trials)
• Los Angeles (10 trials)
• San Diego (6 trials)
• Glendale (5 trials)
• Palo Alto (5 trials)
• La Jolla (4 trials)
• Los Alamitos (4 trials)
• Escondido (3 trials)

Who Can Participate?

Participation in clinical trials is open to a diverse range of individuals. Of the 5 new trials launched this month, all 5 include older adults, ensuring that senior populations have ample opportunity to contribute to medical science. Currently, no new trials are specifically designed for children, or exclusively for female or male participants. With 31 trials actively seeking healthy volunteers in Duarte, there are numerous avenues for individuals without specific medical conditions to support medical research.

As we move further into spring, the focus will remain on the ongoing enrollment in these significant Phase 3 trials and the continued exploration of new therapeutic strategies, with Duarte's robust research community at the forefront of medical innovation.